GeneBioTech Co. Ltd Market Cap ($28.82 Million)
Market Cap & Net Worth: GeneBioTech Co. Ltd (086060)
GeneBioTech Co. Ltd market cap. GeneBioTech Co. Ltd (KQ:086060) has a market capitalization of $28.82 Million (₩42.52 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23731 globally and #1643 in its home market, demonstrating a -0.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GeneBioTech Co. Ltd's stock price ₩5080.00 by its total outstanding shares 8370460 (8.37 Million). Also see 086060 cash flow conversion for how efficiently the company converts equity into cash flow.
GeneBioTech Co. Ltd Market Cap History (2015–2026)
GeneBioTech Co. Ltd market cap history from 2015 to 2026. Data shows growth from $26.43 Million to $28.82 Million (3.13% CAGR). Check GeneBioTech Co. Ltd (086060) stock price for real-time trading data and today's change.
Index Memberships
GeneBioTech Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.01% | #833 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.01% | #833 of 1384 |
Weight: GeneBioTech Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GeneBioTech Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GeneBioTech Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GeneBioTech Co. Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
GeneBioTech Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
GeneBioTech Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $31.14 Million | $55.63 Billion | $2.73 Billion | 0.00x | 0.01x |
| 2017 | $26.05 Million | $55.53 Billion | $2.09 Billion | 0.00x | 0.01x |
| 2018 | $22.68 Million | $62.81 Billion | $2.68 Billion | 0.00x | 0.01x |
| 2019 | $31.52 Million | $58.24 Billion | $846.78 Million | 0.00x | 0.04x |
| 2020 | $32.43 Million | $59.12 Billion | -$2.34 Billion | 0.00x | N/A |
| 2021 | $29.72 Million | $62.81 Billion | -$484.40 Million | 0.00x | N/A |
| 2022 | $22.63 Million | $82.76 Billion | $1.52 Billion | 0.00x | 0.01x |
| 2023 | $24.73 Million | $79.48 Billion | $2.59 Billion | 0.00x | 0.01x |
| 2024 | $18.66 Million | $82.96 Billion | $2.87 Billion | 0.00x | 0.01x |
| 2025 | $22.75 Million | $90.79 Billion | $3.79 Billion | 0.00x | 0.01x |
Competitor Companies of 086060 by Market Capitalization
Companies near GeneBioTech Co. Ltd in the global market cap rankings as of November 4, 2026. Also see GeneBioTech Co. Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to GeneBioTech Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5272 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.49 Billion | ₩171400.00 |
| #8989 | ST Pharm Co.Ltd | KQ:237690 | $902.70 Million | ₩71400.00 |
| #9557 | NatureCell Co.Ltd | KQ:007390 | $793.12 Million | ₩22050.00 |
| #10371 | Oscotec Inc | KQ:039200 | $674.16 Million | ₩35400.00 |
Market Capitalization of GeneBioTech Co. Ltd (2015–2026)
Market capitalization of GeneBioTech Co. Ltd from 2015 to today. Between 2015 and today, GeneBioTech Co. Ltd's market cap moved from $26.43 Million to $ 28.82 Million, with a yearly change of 3.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩28.82 Million | +26.68% |
| 2025 | ₩22.75 Million | +21.88% |
| 2024 | ₩18.66 Million | -24.54% |
| 2023 | ₩24.73 Million | +9.27% |
| 2022 | ₩22.63 Million | -23.85% |
| 2021 | ₩29.72 Million | -8.34% |
| 2020 | ₩32.43 Million | +2.87% |
| 2019 | ₩31.52 Million | +39.02% |
| 2018 | ₩22.68 Million | -12.94% |
| 2017 | ₩26.05 Million | -16.34% |
| 2016 | ₩31.14 Million | +17.81% |
| 2015 | ₩26.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of GeneBioTech Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.82 Million USD |
| MoneyControl | $28.82 Million USD |
| MarketWatch | $28.82 Million USD |
| marketcap.company | $28.82 Million USD |
| Reuters | $28.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GeneBioTech Co. Ltd
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. It offers functional feed ingredients and additives, as well as veterinary medicines. The company was founded in 1984 and is headquartered in Gongju, South Korea.